Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia
- PMID: 31255419
- DOI: 10.1016/j.jfma.2019.05.023
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia
Abstract
Background: To determine the association between amiodarone or lidocaine and outcomes in adult in-hospital cardiac arrest (IHCA) with shock-refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT).
Methods: A retrospective study in a single medical centre was conducted. Patients experiencing an IHCA between 2006 and 2015 were screened. Shock-refractory ventricular tachyarrhythmias were defined as VF/pVT requiring more than one defibrillation attempt. A multivariate logistic regression analysis was used to study the associations between the independent variables and outcomes.
Results: A total of 130 patients were included. Among these, 113 patients (86.9%) were administered amiodarone as the first antiarrhythmic agent (amiodarone first) following VF/pVT, and the other patients were administered lidocaine (lidocaine first). The median time to the first defibrillation and first antiarrhythmic drug administration were 2 and 9 min, respectively. The analysis demonstrated that the amiodarone-first group experienced a higher likelihood of terminating the VF/pVT within three shocks (odds ratio: 11.61, 95% confidence interval: 1.34-100.84; p-value = 0.03), as compared with the lidocaine-first group. However, there were no significant differences between the amiodarone- and lidocaine-first groups in sustained return of spontaneous circulation, survival for 24 h, survival, or favourable neurological outcomes at hospital discharge.
Conclusion: For patients with IHCA and shock-refractory VF/pVT, the adoption of an amiodarone-first strategy seemed to be associated with the termination of VF/pVT using fewer shocks. Nonetheless, because of the small sample size, additional large-scale studies should be conducted to investigate whether this advantage could be translated into a long-term benefit in survival or neurological outcomes.
Keywords: Amiodarone; Arrhythmia; Cardiopulmonary resuscitation; In-hospital cardiac arrest; Lidocaine.
Copyright © 2019. Published by Elsevier B.V.
Similar articles
-
Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.Resuscitation. 2014 Mar;85(3):381-6. doi: 10.1016/j.resuscitation.2013.12.008. Epub 2013 Dec 19. Resuscitation. 2014. PMID: 24361455 Free PMC article.
-
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).Circulation. 2017 Nov 28;136(22):2119-2131. doi: 10.1161/CIRCULATIONAHA.117.028624. Epub 2017 Sep 13. Circulation. 2017. PMID: 28904070 Free PMC article. Clinical Trial.
-
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.N Engl J Med. 2016 May 5;374(18):1711-22. doi: 10.1056/NEJMoa1514204. Epub 2016 Apr 4. N Engl J Med. 2016. PMID: 27043165 Clinical Trial.
-
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?Curr Opin Crit Care. 2018 Jun;24(3):138-142. doi: 10.1097/MCC.0000000000000498. Curr Opin Crit Care. 2018. PMID: 29561289 Review.
-
Pharmacologic treatment of cardiac arrest.Prehosp Emerg Care. 1999 Oct-Dec;3(4):279-82. doi: 10.1080/10903129908958954. Prehosp Emerg Care. 1999. PMID: 10534025 Review.
Cited by
-
Effectiveness of Amiodarone in Preventing the Occurrence of Reperfusion Ventricular Fibrillation After the Release of Aortic Cross-Clamp in Open-Heart Surgery Patients: A Meta-Analysis.Front Cardiovasc Med. 2022 Feb 4;9:821938. doi: 10.3389/fcvm.2022.821938. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35187132 Free PMC article.
-
Comparison of the Effects of Lidocaine and Amiodarone on Patients With Cardiac Arrest: A Systematic Review and Meta-Analysis.Cureus. 2024 Mar 12;16(3):e56037. doi: 10.7759/cureus.56037. eCollection 2024 Mar. Cureus. 2024. PMID: 38623114 Free PMC article. Review.
-
Effect of Stellate Ganglion Block Combined with Lidocaine at Different Concentrations for Preemptive Analgesia on Postoperative Pain Relief and Adverse Reactions of Patients Undergoing Laparoscopic Cholecystectomy.Comput Math Methods Med. 2022 Apr 11;2022:6027093. doi: 10.1155/2022/6027093. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2022 Nov 24;2022:9804601. doi: 10.1155/2022/9804601. PMID: 35450203 Free PMC article. Retracted. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical